Today: 2 June 2026
BAE Systems share price ends week higher as Trump defence-budget call lifts European defence stocks
10 January 2026
1 min read

BAE Systems share price ends week higher as Trump defence-budget call lifts European defence stocks

London, Jan 10, 2026, 08:04 GMT — Market closed

  • BAE Systems closed at 2,053p on Friday, up 1.48% on the day
  • Defence stocks surged this week on geopolitics and shifting U.S. defence policy signals
  • Investors now look to BAE’s Feb. 18 full-year results for guidance and cash-return clues

BAE Systems shares ended the week firmer after a sharp two-day run that left the stock close to recent highs. The stock closed at 2,053 pence on Friday, up 1.48%, after rising 5.04% on Thursday.

The move has tracked a wider bid for defence names after U.S. President Donald Trump called for a steep rise in U.S. military spending and floated limits on dividends and share buybacks — when a company repurchases its own stock — unless contractors speed up weapons output. “Geopolitics is the inescapable story of 2026 thus far,” Neil Wilson, UK investor strategist at Saxo Bank, said, while RBC Capital Markets analysts led by Ken Herbert flagged “significant uncertainty” over where a final U.S. defence budget lands. Reuters

In London, defence stocks hit a record high on Thursday even as the broader FTSE 100 ended flat, pinned back by energy and retailers. BAE gained about 5% on the day and touched its highest level since October, Reuters data showed.

Technically, the stock is pressing back toward its 52-week high, after closing Thursday at 2,023p — about 2.4% below the £20.73 peak hit in October, according to MarketWatch data. Traders will also keep an eye on the round 2,000p area, which has acted as a psychological line during fast moves.

What happens next may hinge less on BAE itself and more on headlines out of Washington. Investors are trying to work out whether the proposed jump in U.S. spending is real money, political messaging, or something that gets watered down in Congress, and what any restrictions on U.S. contractors would mean in practice.

There’s a risk the trade has run ahead of itself. If geopolitical tensions cool, or if the White House steps back from the toughest language on capital returns, some of the defensive bid could leak out quickly, especially with many European defence stocks already near highs.

The next hard catalyst for BAE is its full-year results on Feb. 18, when investors will look for guidance on 2026 sales and margins, order intake, and cash flow.

BAE also has a multi-year share buyback programme in place — cash used to retire shares can support earnings per share — which will stay in focus given the U.S. debate over capital returns in the sector.

Latest articles

Hims Kicks Off $1.15 Billion Global Push; Shares Hold Back

Hims Kicks Off $1.15 Billion Global Push; Shares Hold Back

2 June 2026
Hims & Hers shares slipped 0.9% after closing the $1.15 billion Eucalyptus buyout, adding 850,000 customers and expanding internationally, but investors face execution risks and uncertainty around U.S. weight-loss drug plans as first-quarter revenue missed forecasts and subscriber revenue fell.
HIVE Stock Sees 158% Revenue Surge, Big Tasks Ahead

HIVE Stock Sees 158% Revenue Surge, Big Tasks Ahead

2 June 2026
HIVE Digital Technologies shares rose to $4.89 after reporting a 158% jump in fiscal 2026 revenue to $297.8 million, driven mainly by digital-currency mining, but a weak fourth quarter and Bitcoin’s 4.5% drop limited gains; investors are watching if HIVE’s AI infrastructure push can offset crypto volatility and sustain future growth.
CrowdStrike’s 70% AI Rally Faces One Hard Test This Week

CrowdStrike’s 70% AI Rally Faces One Hard Test This Week

2 June 2026
CrowdStrike shares slipped 2.2% to $764.67 as investors await Wednesday’s fiscal Q1 results, with options pricing in a possible 9.5% swing; the stock is up nearly 70% this year on AI-driven cyber defense hopes, but is trading well above the average analyst target and faces pressure to show that AI demand is translating into lasting subscription growth.
Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement

Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement

2 June 2026
Bluejay Diagnostics (BJDX) soared up to 213% in premarket trading after announcing a U.S. manufacturing deal with Argonaut for its Symphony test system, but shares remain volatile as Symphony still awaits FDA clearance, clinical enrollment is incomplete, and Bluejay warns it will need more funding within a year or may face liquidation if capital can’t be raised.
VSXY opens strong as Victoria’s Secret smashes earnings

VSXY opens strong as Victoria’s Secret smashes earnings

2 June 2026
Victoria’s Secret & Co. shares soared up to 39% in early trading after the company raised its annual sales and profit outlook, reported Q1 net sales up 15% to $1.56 billion, and posted adjusted EPS of 60 cents—double analyst estimates—while launching its new VSXY ticker, fueling investor optimism for CEO Hillary Super’s turnaround.
Singapore Airlines stock slips again as oil firms; Feb 24 update looms
Previous Story

Singapore Airlines stock slips again as oil firms; Feb 24 update looms

Rio Tinto stock slides on Glencore merger talks as Feb 5 takeover deadline looms
Next Story

Rio Tinto stock slides on Glencore merger talks as Feb 5 takeover deadline looms

Go toTop